Company profile
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ: LABT · Healthcare · Biotechnology
PublicHQ University Park, FLCIK 0002079272Reports USD
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 16
v0.1 · 5/100 weight · pillars only
↑ market scale, filing timeliness · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
5
as of 2026-08-02
Market cap
$947.2k
as of 2026-08-02
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Lakewood-Amedex Biotherapeutics Inc. Common Stock’s financial profile?
Lakewood-Amedex Biotherapeutics Inc. Common Stock has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Tocca Life Holdings Inc——PharmaCom BioVet, Inc.——Suvanza Pharma, LLC——RushNet, Inc.——ZyVersa Therapeutics, Inc.——XORTX Therapeutics Inc.——Key facts
CEOKelvin Cooper
SectorHealthcare
IndustryBiotechnology
HeadquartersUniversity Park, FL
ExchangeNASDAQ: LABT
Employees5
IPO date2026-04-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.